Approximately 10% to 15% of all premenopausal women and 25% to 35% of infertile women experience pelvic pain and menstrual irregularities caused by endometriosis (Figure). There is a strong genetic component to endometriosis. A woman faces a 7-fold chance of developing endometriosis if her mother had endometriosis. Medical treatment consists of suppressing the menstrual cycle with oral contraceptives or more powerful medications. If this fails, the disease implants and adhesions often require open or laparoscopic surgical removal to relieve the symptoms. However, surgery poses the risk of infertility if excessive ovarian tissue and follicles are removed and adhesions form.
Reproductive endocrinology specialists confirm a suspected diagnosis of endometriosis through laparoscopic examination and tissue biopsy. If a woman has completed childbearing or has no desire to bear children and wants to keep her pelvic organs, the focus of the pelvic examination is to determine areas of the pelvis that are most affected and to surgically remove the deposits.
If the woman desires to bear children - or the endometriosis is in locations too difficult to reach surgically - medical therapies may be used in conjunction with surgery. These therapies include continuous oral contraceptives or the use of injectable GnRH analogs to reduce estrogen production and thereby restrict growth of adhesions. Medical therapy alone does not seem to markedly increase fertility.
At Mayo Clinic, the multidisciplinary reproductive endocrinology team strives to preserve or improve fertility in several ways:
To learn more about evaluation and treatment of endometriosis and Mayo Clinic reproductive endocrinology specialties or to refer patients for evaluations, call 507-284-9792.